Vincristine neuropathy: Neurophysiological and genetic studies in a case of Wilms tumor

Pediatric Blood and Cancer

Volumn 43, Issue 5, 2004, Pages 606-609

  Schiavetti, Amalia ^a   Frascarelli, Massimo ^a   Uccini, Stefania ^a   Novelli, Antonio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Charcot Marie Tooth; Children; Vincristine; Wilms tumor

Indexed keywords

VINCRISTINE;

ARTICLE; CASE REPORT; CHROMOSOME 17P; CHROMOSOME DUPLICATION; ELECTRODIAGNOSIS; FEMALE; GENETIC ANALYSIS; HUMAN; NEPHROBLASTOMA; NEUROPATHY; NEUROPSYCHOLOGY; NEUROTOXICITY; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 4744356134     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20123     Document Type: Article

References (21)

1. Balis FM, Holcemberg JS, Blaney SM. General principles of chemotherapy. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 4th edition. Philadelphia-New York: Lippincott; 2002. pp 237-308.
2. Weiden PL, Wright SE. Vincristine neurotoxocity. N Engl J Med 1972;286:1369-1370.
3. Hogan-Dann CM, Fellmeth WG, McGuire SA, et al. Polyneuropathy following vincristine therapy in two patients with Charcot-Marie-Tooth syndrome. JAMA 1984;252:2862-2863.
4. Griffiths JD, Stark RJ, Ding JC, et al. Vincristine neurotoxicity in Charcot-Marie-Tooth syndrome. Med J Aust 1985;143:305-306.
5. Dickerhoff R, Lindner W, Scheiber W. Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease. Pediatr Hematol Oncol 1988;5:61-64.
6. McGuire SA, Gospe SM, Dahl G. Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type I. Med Pediatr Oncol 1989;17:520-523.
7. Igarashi M, Thompson EI, Rivera GK. Vincristine neuropathy in type I and type II Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy). Med Pediatr Oncol 1995;25:113-116.
8. Geny C, Gaio JM, Mallaret M, et al. Charcot-Marie-Tooth disease discosed by a treatment with vincristine in familial Hodgkin's disease. Ann Med Interne 1990;141:709-710.
9. Neumann Y, Toren A, Rechavi G, et al. Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease. Med Pediatr Oncol 1996;26:280-283.
10. Graf WD, Chance PF, Lensch MW, et al. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A. Cancer 1996;77:1356-1362.
11. Olek MJ, Bordeaux B, Leshner RT. Charcot-Marie-Tooth disease type I diagnosed in a 5-year-old boy after vincristine neurotoxicity, resulting in maternal diagnosis. JAOA 1999;99:165-167.
12. Mercuri E, Poulton J, Buck J, et al. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A. Arch Dis Child 1999;81:442-443.
13. Hildebrandt G, Holler E, Woenkhaus M, et al. Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy. Ann Oncol 2000;11:743-747.
14. Trobaugh-Lotario AD, Smith AA, Odom LF. Vincristine neurotoxicity in the presence of hereditary neuropathy. Med Pediatr Oncol 2003;40:39-43.
15. Chauvenet AR, Shashi V, Selsky C, et al. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: A Pediatric Oncology Group Study. J Pediatr Hematol Oncol 2003;25:316-320.
16. Chance PF, Abbas N, Lensh MW, et al. Two autosomal dominant neuropathies from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 1994;3:1503-1507.
17. De Jonghe P, Timmerman V, Nelis E, et al. Charcot-Marie-Tooth and related peripheral neuropathies. J Peripher Nerv Syst 1997;2:360-387.
18. Lopes J, LeGuern E, Gouider R, et al. Recombination hot spot in a 3.2-kb region of the Charcot-Marie-Tooth type 1A repeat sequences: New tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth type 1A. Am J Hum Genet 1996;58:1223-1230.
19. Murakami T, Garcia CA, Reiter LT, et al. Charcot-Marie-Tooth disease and related inherited neuropathies. Medicine 1996;75:233-250.
20. Birouk N, Goudier R, Le Gueru E, et al. Charcot-Marie-Tooth disease type I a with 17p11.2 duplication. Clinical and electrophysiological phenothype study and factors influencing disease severity in 119 cases. Brain 1997;120:813.
21. Gutman L, Fakadej A, Riggs JE. Evolution of nerve conduction abnormalities in children with dominant hypertrofic neuropathy of the Charcot-Marie-Tooth type. Muscle Nerve 1983;6:515-516.